Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alison M Yeomans
Targeted Inhibition of mRNA Translation Initiation Factors as a Novel Therapeutic Strategy for Mature B-Cell Neoplasms
Related publications
Substrate-Selective COX-2 Inhibition as a Novel Strategy for Therapeutic Endocannabinoid Augmentation
Trends in Pharmacological Sciences
Toxicology
Pharmacology
Inhibition of C-Met Is a Potential Therapeutic Strategy for Treatment of Diffuse Large B-Cell Lymphoma
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
DDR1 Inhibition as a New Therapeutic Strategy for Colorectal Cancer
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Targeted Inhibition of Pancreatic Acinar Cell Calcineurin Is a Novel Strategy to Prevent Post-Ercp Pancreatitis
Cellular and Molecular Gastroenterology and Hepatology
Hepatology
Gastroenterology
MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Utilizing TH9 Cells as a Novel Therapeutic Strategy for Malignancies
OncoImmunology
Oncology
Allergy
Immunology
Translation Initiation of the HIV-1 mRNA
Translation
Biochemistry
Developmental Biology
Cell Biology
Molecular Biology
Combined PPARg Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors
Molecular Cancer Therapeutics
Cancer Research
Oncology
P1.03-13 eIF2β, a Subunit of Translation-Initiation Factor EIF2, as a Potential Therapeutic Target for Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary